Novack David F's Form 4 filing
Dynavax Technologies Corp (DVAX) · filed Dec 29, 2025
- Accession no.
- 0001628280-25-058985
- Filed
- Dec 29, 2025
- Trade date
- Dec 23-24, 2025
- Filing delay
- 6 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 4 derivative transactions. Open-market sales total $464.7K. It was filed 6 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Novack David FCIK 0001573072 | Officer (President & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Common Stock | AGrant or awardAcquired | +60,625 | –F2 | – | 70,043 | Direct | |
| Dec 23, 2025 | Common Stock | MOption exerciseAcquired | +22,620 | –F4 | – | 92,663 | Direct | |
| Dec 23, 2025 | Common Stock | MOption exerciseAcquired | +18,788 | –F4 | – | 111,451 | Direct | |
| Dec 24, 2025 | Common Stock | MOption exerciseAcquired | +20,000 | $6.81 | +$136,200 | 131,451 | Direct | |
| Dec 24, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $10.47 | +$104,700 | 141,451 | Direct | |
| Dec 24, 2025 | Common Stock | SSaleDisposed | −30,000 | $15.49 | −$464,700 | 111,451 | Direct | |
| Dec 24, 2025 | Common Stock | FTax withholdingDisposed | −48,107 | $15.38 | −$739,885.66 | 63,344 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Common Stock | MOption exerciseDisposed | −22,620 | –F4 | – | 22,620 | Direct | |
| Dec 23, 2025 | Common Stock | MOption exerciseDisposed | −18,788 | –F4 | – | 37,576 | Direct | |
| Dec 24, 2025 | Common Stock | MOption exerciseDisposed | −20,000 | –F10 | – | 166,528 | Direct | |
| Dec 24, 2025 | Common Stock | MOption exerciseDisposed | −10,000 | –F10 | – | 85,655 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents PSUs previously granted to the Reporting Person that vest based on how the Issuer's total stockholder return compares to the total stockholder return of an indexed group of companies ("rTSR") over a performance period ending on December 31, 2025. Each PSU represents a contingent right to receive one share of common stock. On the Effective Date, the Board of Directors of the Issuer determined that these PSUs (which represent 125% of the target number of PSUs) were earned according to achievement of the rTSR performance condition over a shortened performance period, with the Issuer's total stockholder return determined based on the amount payable for a share of the Issuer's common stock pursuant to the Merger Agreement ($15.50), and approved such acceleration of vesting of the earned PSUs.
Referenced by the price of 1 transaction in Table I.
- F4
Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.
- F10
Not applicable.
Referenced by the price of 2 transactions in Table II.